Anthocyanin supplementation in adults at risk for dementia: a randomized controlled trial on its cardiometabolic and anti-inflammatory biomarker effects.
- 2025-05-02
- RCT · n = 99
- GeroScience 48(1)
- Miguel German Borda
- Robinson Ramírez-Vélez
- Felipe Botero-Rodriguez
- Jonathan Patricio-Baldera
- Chiara de Lucia
- Ilaria Pola
- George E Barreto
- Khadija Khalifa
- Anne Katrine Bergland
- Miia Kivipelto
- Tommy Cederholm
- Henrik Zetterberg
- Nicholas J Ashton
- Clive Ballard
- Richard Siow
- Dag Aarsland
- PubMed: 40314845
- DOI: 10.1007/s11357-025-01669-8
- High evidence
- Clinical
The biomarkers analyzed included inflammatory biomarker assessment (IL‑6, IL‑8, IL‑10, IL‑1b, TNF‑α, IFN‑γ), ... which were longitudinally compared between both groups.
- Effect
- Neutral
- Effect size
- Small
- Significant
- No
- Dose
- 320 mg/day